Reviewing Scientific Industries (OTCMKTS:SCND) & Standard BioTools (NASDAQ:LAB)

Scientific Industries (OTCMKTS:SCNDGet Rating) and Standard BioTools (NASDAQ:LABGet Rating) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends.

Analyst Ratings

This is a summary of recent recommendations and price targets for Scientific Industries and Standard BioTools, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scientific Industries 0 0 0 0 N/A
Standard BioTools 0 0 0 0 N/A

Volatility and Risk

Scientific Industries has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500. Comparatively, Standard BioTools has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Earnings and Valuation

This table compares Scientific Industries and Standard BioTools’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Scientific Industries $9.77 million 4.24 -$3.67 million N/A N/A
Standard BioTools $130.58 million 1.12 -$59.24 million ($1.52) -1.24

Scientific Industries has higher earnings, but lower revenue than Standard BioTools.

Profitability

This table compares Scientific Industries and Standard BioTools’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Scientific Industries -44.85% -19.16% -17.19%
Standard BioTools -93.89% -63.43% -18.45%

Institutional and Insider Ownership

11.3% of Scientific Industries shares are held by institutional investors. 27.7% of Scientific Industries shares are held by insiders. Comparatively, 2.9% of Standard BioTools shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Scientific Industries beats Standard BioTools on 7 of the 9 factors compared between the two stocks.

About Scientific Industries

(Get Rating)

Scientific Industries, Inc. designs, manufactures, and markets benchtop laboratory equipment and bioprocessing systems worldwide. It offers vortex mixers to mix the contents of test tubes, beakers, and other containers by placing such containers on a rotating cup or other attachments; and various mixers and shakers, such as high speed touch mixers, mixers with an integral timer, cell disruptors, microplate mixers, vortex mixers incorporating digital control and display, multi-vessel vortex mixers, and orbital shakers. The company also provides benchtop multi-purpose rotators and rockers to rotate and rock various containers; refrigerated incubators and incubated shakers for shaking and stirring functions; and magnetic stirrers, including high/low programmable magnetic stirrers, four-place high/low programmable magnetic stirrers, large volume magnetic, and four-place general purpose stirrers. In addition, it offers bioprocessing systems comprising disposable sensors, such as coaster systems and other shaking products using vessels; and mechanical balances, moisture analyzers, pill counters, test stands, and force gauges, as well as pharmacy, laboratory, and industrial digital scales. The company's products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, petrochemical companies, and other industries performing laboratory-scale research. The company markets its products under the Genie and Torbal brand names directly, as well as through laboratory equipment distributors and online. Scientific Industries, Inc. was incorporated in 1954 and is headquartered in Bohemia, New York.

About Standard BioTools

(Get Rating)

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Receive News & Ratings for Scientific Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scientific Industries and related companies with MarketBeat.com's FREE daily email newsletter.